HRS-1893 - Jiangsu Hengrui Pharma
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects (clinicaltrials.gov) - Dec 30, 2025 - P1 | N=38 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting 
Enrollment open • Cardiomyopathy • Cardiovascular
http://clinicaltrials.gov/ct2/show/NCT07272330
 
Dec 30, 2025
 
Prev Next